Pharmacist-Led Interventions to Increase Access to Medications for Opioid Use Disorder
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 267
- 试验地点
- 2
- 主要终点
- Retention
研究概览
简要总结
The purpose of this study is to investigate the impact of a pharmacist-led intervention to expand access to medications for opioid use disorder (MOUD) on racial/ethnic differences in opioid-related overdose among individuals diagnosed with opioid use disorder (OUD) currently incarcerated in a carceral setting. In this study, participants will be screened for opioid use, trained to administer Narcan nasal spray, receive motivational counseling and referral to treatment post-release from a carceral setting (a Re-Entry program) into the community.
详细描述
The main objectives of this study are:
- To increase understanding of racial/ethnic differences in the prevalence of OUD.
- To test if a pharmacist-led intervention is more effective than a substance use counselor (lay person) in increasing knowledge and confidence among different racial/ethnic groups related to administering Narcan nasal spray in an opioid overdose situation.
- To test if a pharmacist-delivered an evidence-based intervention, q brief intervention and referral to treatment (BIRT) versus standard medication counseling (SMC) is more effective in increasing access to MOUD.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Prevention
- 盲法
- Single (Participant)
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Narcan Training:
- •a Re-Entry program participant 7-14 days from release from carceral setting
- •provide collateral contact information for ≥2 persons (to ensure consistent contact/follow up)
- •have a reliable landline or mobile phone to be contacted by pharmacist
- •plan to remain in the Little Rock area for at least 6 months
- •able to read and write English
- •able to provide informed consent
- •possesses manual dexterity; physical ability to roll a person onto her/his/their back and side
- •have no allergy to naloxone hydrochloride (active ingredient in Narcan nasal spray)-
- •identified on the RODS screener as positive for OUD.
- •a Re-Entry program participant 7-14 days from release from the carceral setting
- •provide contact information for ≥2 persons (to ensure consistent contact/follow -up)
- •have a reliable landline or mobile phone to be contacted by pharmacist
- •plan to remain in the Little Rock area for at least 6 months
- •able to read and write English; able to provide informed consent
- •identified with OUD.
排除标准
- •Narcan training:
- •not a RE-entry program participant
- •identified substance use disorders other than OUD
- •not a RE-entry program participant
- •identified substance use disorders other than OUD
研究组 & 干预措施
Pharmacist Narcan Training
Pharmacist-led intervention
干预措施: Pharmacist Narcan Training (Behavioral)
Substance Use Counselor Narcan Training
Non-clinician intervention
干预措施: Substance Use Counselor Narcan Training (Behavioral)
Brief Intervention and Referral to Treatment (BIRT)
BIRT intervention
干预措施: BIRT (Behavioral)
Standard Medication Counseling (SMC)
SMC intervention
干预措施: SMC (Behavioral)
结局指标
主要结局
Retention
时间窗: at month 6
Participants, regardless of treatment arm, will receive follow-up telephone interviews at 6 months post-release from the carceral setting into the community. Interviews will address the primary question whether MOUD treatment was initiated and maintained.
Opioid overdose training
时间窗: at month 6
Participants' knowledge about opioid overdose and confidence to recognize and respond to opioid overdose situations as a function of the trainer. Participants will complete a brief validated survey, the adapted Perceived Competence Scale. The questions on the survey are rated on a 7-point scale and participants indicate how true four statements are about their ability to recognize and respond to overdoses: the scale, 1 (not at all true) to 7 (very true).
次要结局
未报告次要终点